Mild antecedent COVID-19 associated with symptom-specific post-acute sequelae.
Tiffany A WalkerAlex D TruongAerica SummersAdviteeya N DixitFelicia C GoldsteinIhab HajjarMelvin R EcholsMatthew C WoodruffErica D LeeSeema TekwaniKelley CarrollIgnacio SanzF Eun-Hyung LeeJenny E HanPublished in: PloS one (2023)
Mild antecedent COVID-19 was associated with highly prevalent symptoms, and those treated with remdesivir developed less fatigue and cognitive impairment. Sequelae had a delayed peak, ranging 3-12 months post infection, and many did not improve over time, underscoring the importance of targeted preventative measures.